These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31971602)

  • 21. Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis.
    Lin CP; Merola JF; Wallace EB
    Curr Opin Pharmacol; 2022 Dec; 67():102292. PubMed ID: 36228472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comorbidities in psoriatic arthritis].
    Boehncke WH; Boehncke S
    Z Rheumatol; 2013 Oct; 72(8):779-83. PubMed ID: 23934051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating Cardiovascular Impacts of Drugs for Psoriatic Disease: A Long Way to Go.
    Siebert S; Sattar N
    J Invest Dermatol; 2021 Oct; 141(10):2322-2325. PubMed ID: 34560915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiometabolic Disorders in Psoriatic Disease.
    Sobchak C; Eder L
    Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can early treatment with biologicals modify the natural history of comorbidities?
    Vena GA; Vestita M; Cassano N
    Dermatol Ther; 2010; 23(2):181-93. PubMed ID: 20415826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperlipidaemia in psoriatic disease: higher prevalence in psoriatic arthritis and inverse association with systemic therapy.
    Queiro R; Fernández S; Pardo E
    Rheumatology (Oxford); 2021 Aug; 60(8):3949-3951. PubMed ID: 33871582
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoriasis comorbidities.
    Guenther L; Gulliver W
    J Cutan Med Surg; 2009; 13 Suppl 2():S77-87. PubMed ID: 19799830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
    Radner H; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-morbidity in psoriasis: mechanisms and implications for treatment.
    Lønnberg AS; Skov L
    Expert Rev Clin Immunol; 2017 Jan; 13(1):27-34. PubMed ID: 27426230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011.
    Armstrong AW; Schupp C; Bebo B
    Dermatology; 2012; 225(2):121-6. PubMed ID: 23108113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis.
    Maximilian R; Garbe C; Petersen J; Augustin M; Kirsten N; Biermann MHC; Häberle BM; Hagenström K
    Acta Derm Venereol; 2021 Oct; 101(10):adv00566. PubMed ID: 34263331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of comorbidities in psoriasis.
    Naldi L; Mercuri SR
    Dermatol Ther; 2010; 23(2):114-8. PubMed ID: 20415817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comorbidities and psoriasis. Impact on clinical practice].
    Gerdes S; Mrowietz U
    Hautarzt; 2012 Mar; 63(3):202-13. PubMed ID: 22373901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Coates LC; Espinoza LR; Ogdie AR; Rich P; Soriano ER
    J Rheumatol; 2013 Aug; 40(8):1438-41. PubMed ID: 23908541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
    Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
    Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term control of psoriasis is necessary].
    Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.
    Schmitt J; Ford DE
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):885-92. PubMed ID: 20015170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.